Betaseron and Type 1 diabetes - a phase IV clinical study of FDA data

Summary:

Type 1 diabetes is reported as a side effect among people who take Betaseron (interferon beta-1b), especially for people who are female, 50-59 old, have been taking the drug for 6 - 12 months also take Baclofen, and have Secondary progressive multiple sclerosis.

The phase IV clinical study analyzes which people have Type 1 diabetes when taking Betaseron. It is created by eHealthMe based on reports of 26,754 people who have side effects when taking Betaseron from the FDA, and is updated regularly.

What is Betaseron?

Betaseron has active ingredients of interferon beta-1b. It is often used in multiple sclerosis. eHealthMe is studying from 26,886 Betaseron users. Check the latest studies of Betaseron.

What is Type 1 diabetes?

Type 1 diabetes is found to be associated with 668 drugs and 1,643 conditions by eHealthMe. Check the latest studies of Type 1 diabetes.

On Jul, 07, 2026

26,754 people reported to have side effects when taking Betaseron.
Among them, 16 people (0.06%) have Type 1 diabetes.

Among these 16 people:

How long have people been on Betaseron when they have Type 1 diabetes? *

What is the gender of people who have Type 1 diabetes when taking Betaseron? *

female: 73.33 %
male: 26.67 %

What is the age of people who have Type 1 diabetes when taking Betaseron? *

What are other drugs people take besides Betaseron? *

What are other side effects people have besides Type 1 diabetes? *

Weakness: 7 people, 43.75%
Back Pain: 6 people, 37.50%
Blood Glucose Increased: 6 people, 37.50%
Memory Loss: 5 people, 31.25%
Balance Disorder: 5 people, 31.25%
Pain: 5 people, 31.25%
Liver Function Test Abnormal: 4 people, 25.00%
Limb Injury: 4 people, 25.00%
Protein Urine Present: 4 people, 25.00%
Incontinence (lack of moderation or self-control): 4 people, 25.00%

What are the existing conditions these people have? *

Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 4 people, 25.00%
High Blood Cholesterol: 2 people, 12.50%
Metastatic Neoplasm (spreadable cancer tumour): 1 person, 6.25%
Metastases To Bone (cancer spreads to bone): 1 person, 6.25%
Hypersensitivity: 1 person, 6.25%
Diabetes: 1 person, 6.25%
Breast Cancer Metastatic: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Betaseron and have Type 1 diabetes?

- Check whether Type 1 diabetes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Betaseron:

Betaseron (26,886 reports)

Type 1 diabetes treatments and more:

Type 1 diabetes (46,845 reports)

Browse all side effects of Betaseron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Type 1 diabetes:

Type 1 diabetes (668 drugs)

Browse all the conditions that are associated with Type 1 diabetes:

Type 1 diabetes (1,643 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on interferon beta-1b (the active ingredients of Betaseron) and Betaseron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.